Flyover HealthTech: Rehabbing stroke patients; cancer testing; reducing infections

  • A clinical trial at The Ohio State University is using gene therapy in a new approach to help those suffering from chronic angina who can’t undergo stenting or coronary bypass surgery.
  • Indy-based Eli Lilly is seeking first approval of an autoimmune drug for hair loss. The drug, baricitinib, spurred hair regrowth in patients with a severe form of alopecia areata in a second Phase 3 study.